A number of research firms have changed their ratings and price targets for Elastic (NYSE: ESTC): 8/28/2026 – Elastic had its price target raised by Scotiabank from $58.00 to $84.00. They now have a “sector perform” rating on the stock. 8/28/2026 – Elastic had its “hold” rating reaffirmed by Piper Sandler. 8/28/2026 – Elastic had […]

Several brokerages have updated their recommendations and price targets on shares of Protagonist Therapeutics (NASDAQ: PTGX) in the last few weeks: 9/1/2026 – Protagonist Therapeutics had its price target raised by Barclays PLC from $153.00 to $180.00. They now have an “overweight” rating on the stock. 9/1/2026 – Protagonist Therapeutics had its price target raised […]